Financhill
Sell
41

PG Quote, Financials, Valuation and Earnings

Last price:
$167.33
Seasonality move :
-0.33%
Day range:
$167.50 - $169.87
52-week range:
$144.29 - $180.43
Dividend yield:
2.36%
P/E ratio:
28.98x
P/S ratio:
4.95x
P/B ratio:
7.75x
Volume:
19.3M
Avg. volume:
7.3M
1-year change:
16.78%
Market cap:
$395.8B
Revenue:
$84B
EPS (TTM):
$5.80
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $71B $76.1B $80.2B $82B $84B
Revenue Growth (YoY) 4.83% 7.28% 5.35% 2.27% 2.48%
 
Cost of Revenues $35.3B $37.1B $42.2B $42.8B $40.8B
Gross Profit $35.7B $39B $38B $39.2B $43.2B
Gross Profit Margin 50.32% 51.25% 47.43% 47.86% 51.39%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $20B $21B $20.2B $21.1B $23.3B
Other Inc / (Exp) $438M $86M $570M $668M -$673M
Operating Expenses $20B $21B $20.2B $21.1B $23.3B
Operating Income $15.7B $18B $17.8B $18.1B $19.9B
 
Net Interest Expenses $310M $457M $388M $449M $452M
EBT. Incl. Unusual Items $15.8B $17.6B $18B $18.4B $18.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.7B $3.3B $3.2B $3.6B $3.8B
Net Income to Company $13.1B $14.4B $14.8B $14.7B $15B
 
Minority Interest in Earnings -$76M -$46M -$51M -$85M -$95M
Net Income to Common Excl Extra Items $13B $14.3B $14.7B $14.7B $14.9B
 
Basic EPS (Cont. Ops) $5.13 $5.69 $6.00 $6.07 $6.18
Diluted EPS (Cont. Ops) $4.96 $5.50 $5.81 $5.90 $6.02
Weighted Average Basic Share $2.5B $2.5B $2.4B $2.4B $2.4B
Weighted Average Diluted Share $2.6B $2.6B $2.5B $2.5B $2.5B
 
EBITDA $19.3B $20.9B $21.2B $21.8B $22.6B
EBIT $16.3B $18.1B $18.4B $19.1B $19.7B
 
Revenue (Reported) $71B $76.1B $80.2B $82B $84B
Operating Income (Reported) $15.7B $18B $17.8B $18.1B $19.9B
Operating Income (Adjusted) $16.3B $18.1B $18.4B $19.1B $19.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $19.3B $20.3B $20.6B $21.9B $21.7B
Revenue Growth (YoY) 8.54% 5.28% 1.35% 6.11% -0.61%
 
Cost of Revenues $9.1B $10.4B $10.8B $10.5B $10.4B
Gross Profit $10.2B $10B $9.8B $11.4B $11.3B
Gross Profit Margin 52.68% 49.04% 47.38% 51.99% 52.06%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.9B $5B $4.8B $5.6B $5.5B
Other Inc / (Exp) $142M $110M $139M $132M -$554M
Operating Expenses $4.9B $5B $4.8B $5.6B $5.5B
Operating Income $5.3B $5B $4.9B $5.8B $5.8B
 
Net Interest Expenses $126M $98M $81M $97M $103M
EBT. Incl. Unusual Items $5.3B $5B $5B $5.8B $5.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $989M $909M $1B $1.2B $1.2B
Net Income to Company $4.3B $4.1B $4B $4.6B $4B
 
Minority Interest in Earnings -$31M -$14M -$24M -$35M -$28M
Net Income to Common Excl Extra Items $4.3B $4.1B $3.9B $4.5B $4B
 
Basic EPS (Cont. Ops) $1.69 $1.66 $1.62 $1.89 $1.65
Diluted EPS (Cont. Ops) $1.63 $1.61 $1.57 $1.83 $1.61
Weighted Average Basic Share $2.5B $2.4B $2.4B $2.4B $2.4B
Weighted Average Diluted Share $2.6B $2.6B $2.5B $2.5B $2.5B
 
EBITDA $6.1B $5.9B $5.8B $6.7B $6.1B
EBIT $5.4B $5.1B $5.1B $6B $5.4B
 
Revenue (Reported) $19.3B $20.3B $20.6B $21.9B $21.7B
Operating Income (Reported) $5.3B $5B $4.9B $5.8B $5.8B
Operating Income (Adjusted) $5.4B $5.1B $5.1B $6B $5.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $72.5B $77.1B $80.5B $83.3B $83.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $35.7B $38.3B $42.6B $42.4B $40.8B
Gross Profit $36.8B $38.8B $37.8B $40.9B $43.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $20.1B $21.1B $20.1B $21.9B $23.2B
Other Inc / (Exp) $477M $54M $599M $661M -$1.4B
Operating Expenses $20.1B $21.1B $20.1B $21.9B $23.2B
Operating Income $16.7B $17.7B $17.7B $19B $19.9B
 
Net Interest Expenses $386M $429M $371M $465M $460M
EBT. Incl. Unusual Items $16.8B $17.4B $18B $19.2B $18.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3B $3.2B $3.3B $3.8B $3.7B
Net Income to Company $13.8B $14.2B $14.6B $15.3B $14.4B
 
Minority Interest in Earnings -$83M -$29M -$61M -$96M -$87M
Net Income to Common Excl Extra Items $13.7B $14.1B $14.6B $15.2B $14.3B
 
Basic EPS (Cont. Ops) $5.41 $5.65 $5.95 $6.33 $5.95
Diluted EPS (Cont. Ops) $5.23 $5.47 $5.77 $6.16 $5.80
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $20.2B $20.6B $21.2B $22.8B $22B
EBIT $17.3B $17.8B $18.4B $20B $19B
 
Revenue (Reported) $72.5B $77.1B $80.5B $83.3B $83.9B
Operating Income (Reported) $16.7B $17.7B $17.7B $19B $19.9B
Operating Income (Adjusted) $17.3B $17.8B $18.4B $20B $19B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $19.3B $20.3B $20.6B $21.9B $21.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.1B $10.4B $10.8B $10.5B $10.4B
Gross Profit $10.2B $10B $9.8B $11.4B $11.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.9B $5B $4.8B $5.6B $5.5B
Other Inc / (Exp) $142M $110M $139M $132M -$554M
Operating Expenses $4.9B $5B $4.8B $5.6B $5.5B
Operating Income $5.3B $5B $4.9B $5.8B $5.8B
 
Net Interest Expenses $126M $98M $81M $97M $103M
EBT. Incl. Unusual Items $5.3B $5B $5B $5.8B $5.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $989M $909M $1B $1.2B $1.2B
Net Income to Company $4.3B $4.1B $4B $4.6B $4B
 
Minority Interest in Earnings -$31M -$14M -$24M -$35M -$28M
Net Income to Common Excl Extra Items $4.3B $4.1B $3.9B $4.5B $4B
 
Basic EPS (Cont. Ops) $1.69 $1.66 $1.62 $1.89 $1.65
Diluted EPS (Cont. Ops) $1.63 $1.61 $1.57 $1.83 $1.61
Weighted Average Basic Share $2.5B $2.4B $2.4B $2.4B $2.4B
Weighted Average Diluted Share $2.6B $2.6B $2.5B $2.5B $2.5B
 
EBITDA $6.1B $5.9B $5.8B $6.7B $6.1B
EBIT $5.4B $5.1B $5.1B $6B $5.4B
 
Revenue (Reported) $19.3B $20.3B $20.6B $21.9B $21.7B
Operating Income (Reported) $5.3B $5B $4.9B $5.8B $5.8B
Operating Income (Adjusted) $5.4B $5.1B $5.1B $6B $5.4B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents $16.2B $10.3B $7.2B $8.2B $9.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.2B $4.7B $5.1B $5.5B $6.1B
Inventory $5.5B $6B $6.9B $7.1B $7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.1B $2.1B $2.4B $1.9B $2.1B
Total Current Assets $28B $23.1B $21.7B $22.6B $24.7B
 
Property Plant And Equipment $20.7B $21.7B $21.2B $21.9B $22.2B
Long-Term Investments -- -- -- -- --
Goodwill $39.9B $40.9B $39.7B $40.7B $40.3B
Other Intangibles $23.8B $23.6B $23.7B $23.8B $22B
Other Long-Term Assets $8.3B $10B $11B $11.8B $13.2B
Total Assets $120.7B $119.3B $117.2B $120.8B $122.4B
 
Accounts Payable $12.1B $13.7B $14.9B $14.6B $15.4B
Accrued Expenses $3.5B $4.1B $3.9B $4.1B $4.5B
Current Portion Of Long-Term Debt $2.6B $3.7B $3.8B $4B $3.9B
Current Portion Of Capital Lease Obligations $239M $219M $205M $222M $243M
Other Current Liabilities $2.9B $3.1B $2.9B $3.5B $3B
Total Current Liabilities $33B $33.1B $33.1B $35.8B $33.6B
 
Long-Term Debt $23.5B $23.1B $22.8B $24.4B $25.3B
Capital Leases -- -- -- -- --
Total Liabilities $73.8B $72.7B $70.4B $73.8B $71.8B
 
Common Stock $4.9B $4.9B $4.9B $4.8B $4.8B
Other Common Equity Adj -$16.2B -$13.7B -$12.2B -$12.2B -$11.9B
Common Equity $45.6B $45.5B $45.7B $46B $49.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $357M $276M $265M $288M $272M
Total Equity $46.9B $46.7B $46.9B $47.1B $50.6B
 
Total Liabilities and Equity $120.7B $119.3B $117.2B $120.8B $122.4B
Cash and Short Terms $16.2B $10.3B $7.2B $8.2B $9.5B
Total Debt $34.7B $32B $31.5B $34.6B $32.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $13.4B $10.4B $6.7B $9.7B $12.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $5B $5.7B $5.7B $6.2B $6.3B
Inventory $5.7B $6.3B $7.6B $7.1B $7.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.9B $2B $2.5B $1.9B $1.7B
Total Current Assets $26B $24.3B $22.5B $24.9B $27.4B
 
Property Plant And Equipment $20.9B $21.4B $20.6B $21.6B $22.5B
Long-Term Investments -- -- -- -- --
Goodwill $40.6B $40.5B $38.8B $40.2B $41B
Other Intangibles $23.8B $23.5B $23.5B $23.6B $22.1B
Other Long-Term Assets $8.6B $9.9B $10.9B $12.1B $13.5B
Total Assets $119.9B $119.7B $116.3B $122.5B $126.5B
 
Accounts Payable $11.9B $14.2B $14.8B $14.4B $15.4B
Accrued Expenses $10.4B $10.4B $10.1B $10.9B $10.7B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $30B $36.6B $36.6B $37.2B $36.4B
 
Long-Term Debt $23.9B $20.6B $21.3B $24.1B $25.7B
Capital Leases -- -- -- -- --
Total Liabilities $71.3B $73.3B $71.9B $74.5B $74.3B
 
Common Stock $4.9B $4.9B $4.8B $4.8B $4.8B
Other Common Equity Adj -$15.9B -$14.1B -$12.8B -$12.6B -$10.9B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $394M $297M $259M $321M $300M
Total Equity $48.6B $46.4B $44.3B $48B $52.1B
 
Total Liabilities and Equity $119.9B $119.7B $116.3B $122.5B $126.5B
Cash and Short Terms $13.4B $10.4B $6.7B $9.7B $12.2B
Total Debt $31.7B $32.5B $33B $35.9B $36.2B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $13.1B $14.4B $14.8B $14.7B $15B
Depreciation & Amoritzation $3B $2.7B $2.8B $2.7B $2.9B
Stock-Based Compensation $558M $540M $528M $545M $562M
Change in Accounts Receivable $634M -$342M -$694M -$307M -$766M
Change in Inventories -$637M -$309M -$1.2B -$119M -$70M
Cash From Operations $17.4B $18.4B $16.7B $16.8B $19.8B
 
Capital Expenditures $3.1B $2.8B $3.2B $3.1B $3.3B
Cash Acquisitions -$58M -$34M -$1.4B -$765M -$21M
Cash From Investing $3B -$2.8B -$4.4B -$3.5B -$3.5B
 
Dividends Paid (Ex Special Dividend) -$7.8B -$8.3B -$8.8B -$9B -$9.3B
Special Dividend Paid
Long-Term Debt Issued $20.3B $12.1B $15.7B $21.2B $7.6B
Long-Term Debt Repaid -$15.4B -$16B -$13.8B -$18.2B -$10B
Repurchase of Common Stock -$7.4B -$11B -$10B -$7.4B -$5B
Other Financing Activities -- -- -- -- --
Cash From Financing -$8.4B -$21.5B -$14.9B -$12.1B -$14.9B
 
Beginning Cash (CF) $4.2B $16.2B $10.3B $7.2B $8.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $12.1B -$6B -$2.6B $1.2B $1.5B
Ending Cash (CF) $16.2B $10.3B $7.2B $8.2B $9.5B
 
Levered Free Cash Flow $14.3B $15.6B $13.6B $13.8B $16.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.3B $4.1B $4B $4.6B $4B
Depreciation & Amoritzation $671M $711M $663M $702M $728M
Stock-Based Compensation $89M $116M $105M $125M $105M
Change in Accounts Receivable -$825M -$1B -$740M -$830M -$134M
Change in Inventories -$137M -$409M -$893M -$142M -$188M
Cash From Operations $4.7B $4.6B $4.1B $4.9B $4.3B
 
Capital Expenditures $850M $1.1B $890M $925M $993M
Cash Acquisitions -- -- -$2M -- -$6M
Cash From Investing -$829M -$1B -$832M -$1.2B -$1.1B
 
Dividends Paid (Ex Special Dividend) -$2B -$2.2B -$2.3B -$2.3B -$2.4B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.5B $2.3B $4.7B $4.4B $4.1B
Long-Term Debt Repaid -$5.1B -$1.4B -$2.1B -$2.9B -$1.1B
Repurchase of Common Stock -$2B -$2.8B -$4B -$1.5B -$1.9B
Other Financing Activities -- -- -- -$1M --
Cash From Financing -$6.7B -$3.4B -$3.5B -$2B -$634M
 
Beginning Cash (CF) $16.2B $10.3B $7.2B $8.2B $9.5B
Foreign Exchange Rate Adjustment $31M -$127M -$235M -$156M $116M
Additions / Reductions -$2.8B $209M -$269M $1.6B $2.6B
Ending Cash (CF) $13.4B $10.4B $6.7B $9.7B $12.2B
 
Levered Free Cash Flow $3.9B $3.6B $3.2B $4B $3.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $13.8B $14.2B $14.6B $15.3B $14.4B
Depreciation & Amoritzation $3B $2.8B $2.8B $2.8B $2.9B
Stock-Based Compensation $537M $567M $517M $565M $542M
Change in Accounts Receivable $70M -$529M -$422M -$397M -$70M
Change in Inventories -$225M -$581M -$1.7B $632M -$116M
Cash From Operations $18B $18.3B $16.2B $17.7B $19.2B
 
Capital Expenditures $2.8B $3B $3B $3.1B $3.4B
Cash Acquisitions -$58M -$34M -$1.4B -$763M -$27M
Cash From Investing -$2.9B -$3B -$4.3B -$3.9B -$3.4B
 
Dividends Paid (Ex Special Dividend) -$7.9B -$8.4B -$8.8B -$9B -$9.5B
Special Dividend Paid
Long-Term Debt Issued $21.8B $12.9B $18.1B $20.8B $7.3B
Long-Term Debt Repaid -$20.5B -$12.3B -$14.5B -$19B -$8.2B
Repurchase of Common Stock -$6.4B -$11.8B -$11.3B -$4.9B -$5.4B
Other Financing Activities -- -- -- -- --
Cash From Financing -$11B -$18.2B -$15B -$10.7B -$13.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.1B -$3B -$3.1B $3.1B $2.4B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $15.1B $15.2B $13.2B $14.6B $15.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.3B $4.1B $4B $4.6B $4B
Depreciation & Amoritzation $671M $711M $663M $702M $728M
Stock-Based Compensation $89M $116M $105M $125M $105M
Change in Accounts Receivable -$825M -$1B -$740M -$830M -$134M
Change in Inventories -$137M -$409M -$893M -$142M -$188M
Cash From Operations $4.7B $4.6B $4.1B $4.9B $4.3B
 
Capital Expenditures $850M $1.1B $890M $925M $993M
Cash Acquisitions -- -- -$2M -- -$6M
Cash From Investing -$829M -$1B -$832M -$1.2B -$1.1B
 
Dividends Paid (Ex Special Dividend) -$2B -$2.2B -$2.3B -$2.3B -$2.4B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.5B $2.3B $4.7B $4.4B $4.1B
Long-Term Debt Repaid -$5.1B -$1.4B -$2.1B -$2.9B -$1.1B
Repurchase of Common Stock -$2B -$2.8B -$4B -$1.5B -$1.9B
Other Financing Activities -- -- -- -$1M --
Cash From Financing -$6.7B -$3.4B -$3.5B -$2B -$634M
 
Beginning Cash (CF) $16.2B $10.3B $7.2B $8.2B $9.5B
Foreign Exchange Rate Adjustment $31M -$127M -$235M -$156M $116M
Additions / Reductions -$2.8B $209M -$269M $1.6B $2.6B
Ending Cash (CF) $13.4B $10.4B $6.7B $9.7B $12.2B
 
Levered Free Cash Flow $3.9B $3.6B $3.2B $4B $3.3B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 1.36% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.63% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.53% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock